ClinicalTrials.gov
ClinicalTrials.gov Menu

Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01364064
Recruitment Status : Completed
First Posted : June 2, 2011
Last Update Posted : February 25, 2016
Sponsor:
Collaborator:
Radiation Therapy Oncology Group
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2008
  Actual Study Completion Date : June 2008